Brainsway (BWAY) Capital Expenditures (2018 - 2026)
Brainsway (BWAY) posted quarterly Capital Expenditures of -$769000.0 for Q1 2026, up 26.27% year-on-year from -$609010.6 in Q1 2025, and down 160.94% on a QoQ basis from $1.3 million in Q4 2025.
Brainsway (BWAY) Capital Expenditures (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Capital Expenditures for 8 consecutive years, with -$769000.0 the latest figure, recorded in Q1 2026.
- Quarterly Capital Expenditures rose 26.27% year-over-year to -$769000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (up 64.19% YoY) and the FY2025 annual result came in at -$1.7 million, up 53.95% from the prior year.
- Capital Expenditures slipped to -$769000.0 in Q1 2026 per BWAY's latest filing, from $1.3 million in the prior quarter.
- Over the last five years, Capital Expenditures for BWAY reached as high as $1.3 million in Q4 2025 and fell as low as -$1.5 million in Q2 2023.
- A 4-year average of -$730250.0 and a median of -$823500.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures sank 152.92% — and 2025, when it surged 236.73%.
- Year by year, Capital Expenditures stood at -$442000.0 in 2023, then sank by 108.82% to -$923000.0 in 2024, then jumped by 236.73% to $1.3 million in 2025, then slumped by 160.94% to -$769000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$769000.0, $1.3 million, and -$800000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 76.60 Mn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | -85.46 Mn |
| 10 | Brainsway | 607.70 Mn | 547.93 Mn | 11.68 Mn | -769,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -769,000.00 |
| Mar 31, 2026 | -769,000.00 |
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | -800,000.00 |
| Sep 30, 2025 | -800,000.00 |
| Jun 30, 2025 | -1.17 Mn |
| Jun 30, 2025 | -1.17 Mn |
| Mar 31, 2025 | -1.04 Mn |
| Mar 31, 2025 | -1.04 Mn |
| Dec 31, 2024 | -923,000.00 |
| Dec 31, 2024 | -923,000.00 |
| Sep 30, 2024 | -1.30 Mn |
| Sep 30, 2024 | -1.30 Mn |
| Jun 30, 2024 | -847,000.00 |
| Jun 30, 2024 | -847,000.00 |
| Mar 31, 2024 | -724,000.00 |
| Mar 31, 2024 | -724,000.00 |
| Dec 31, 2023 | -442,000.00 |
| Dec 31, 2023 | -442,000.00 |